J1162 Digoxin immune fab (ovine)
Also known as: Digibind, DigiFab, digoxin antibodies
Digoxin immune fab fragment antigen-binding portion (ovine-derived), an antidote for digoxin toxicity.
In Plain Language
Antidote for digoxin overdose
Clinical Context
Used emergently for treatment of life-threatening digoxin toxicity including ventricular arrhythmias and severe bradycardia from digoxin toxicity.
RVU Information
CPT J1162 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1162?
CPT J1162 (Digoxin immune fab (ovine)) is a J Codes (Drugs) code. Digoxin immune fab fragment antigen-binding portion (ovine-derived), an antidote for digoxin toxicity.
How is J1162 administered?
CPT J1162 is administered by a healthcare provider, typically via injection or infusion. Used emergently for treatment of life-threatening digoxin toxicity including ventricular arrhythmias and severe bradycardia from digoxin toxicity. It is used by Emergency Medicine, Toxicology, Cardiology.
When is CPT J1162 used?
Used emergently for treatment of life-threatening digoxin toxicity including ventricular arrhythmias and severe bradycardia from digoxin toxicity.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.